Is a complete SPRY research report available?

No complete published report is available for ARS Pharmaceuticals, Inc. (SPRY) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · USD

$3.65

-0.09 (-2.3%)· Recorded snapshot

Market cap	362.5M
Revenue (ttm)	116.9M
Net income (ttm)	-215.4M
EPS (ttm)	-$2.18
Shares out	99.4M
Volume	2,216,097
Beta	1.08

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 116.9M
Net income (ttm): -215.4M
EPS (ttm): -$2.18
Market cap: 362.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	होल्ड

Metric	Value
Amount currency	USD
CIK code	0001671858
Company name	ARS Pharmaceuticals, Inc.
Country	United States
Country code	US
CUSIP number	82835W108
Earnings date	2026-11-09
Earnings time	bmo
Employees	200
Employees change	33
Employees growth	19.76%
Enterprise value	$390.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US82835W1080
Last 10-K release date	2026-03-09
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$362.5M
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$3.65
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	SPRY
U.S. state	California
Website	https://ars-pharma.com

Metric

Value

Amount currency

USD

CIK code

0001671858

Company name

ARS Pharmaceuticals, Inc.

Country

United States

Country code

CUSIP number

82835W108

Earnings date

2026-11-09

Earnings time

bmo

Employees

200

Employees change

Employees growth

19.76%

Enterprise value

$390.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2015

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US82835W1080

Last 10-K release date

2026-03-09

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$362.5M

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$3.65

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

SPRY

U.S. state

California

Website

https://ars-pharma.com

Metric	Value
Earnings yield	-59.69%
EV/Sales	3.24x
FCF / EV yield	-51.9%
FCF yield	-56%
Forward EV/Sales	2.65x
Forward P/S	2.46x
P/B ratio	29.64x
P/S ratio	3x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-59.69%

EV/Sales

3.24x

FCF / EV yield

-51.9%

FCF yield

-56%

Forward EV/Sales

2.65x

Forward P/S

2.46x

P/B ratio

29.64x

P/S ratio

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-184.96%
EBITDA margin	-183.57%
Gross margin	58.35%
Operating margin	-184.96%
Pretax margin	-184.31%
Profit margin	-184.24%
Profit per employee	$-1.1M
Revenue per employee	$584,635
ROA	-48.02%
ROA (5Y)	-18.07%
ROCE	-114.65%
ROE	-210.35%
ROE (5Y)	-42.08%
ROIC	-602.38%
SBC / revenue	26.72%
Tax / revenue	-0.07%

Metric

Value

EBIT margin

-184.96%

EBITDA margin

-183.57%

Gross margin

58.35%

Operating margin

-184.96%

Pretax margin

-184.31%

Profit margin

-184.24%

Profit per employee

$-1.1M

Revenue per employee

$584,635

ROA

-48.02%

ROA (5Y)

-18.07%

ROCE

-114.65%

ROE

-210.35%

ROE (5Y)

-42.08%

ROIC

-602.38%

SBC / revenue

26.72%

Tax / revenue

-0.07%

Metric	Value
EPS growth years	0
Gross profit growth	-24.9%
Gross profit growth (Q)	140.58%
Net income growth years	0
Revenue growth	4.08%
Revenue growth (Q)	114.15%
Revenue growth (QoQ)	48.4%
Revenue growth 3Y	711.25%
Revenue growth quarters	2
Revenue growth years	0

Metric

Value

EPS growth years

Gross profit growth

-24.9%

Gross profit growth (Q)

140.58%

Net income growth years

Revenue growth

4.08%

Revenue growth (Q)

114.15%

Revenue growth (QoQ)

48.4%

Revenue growth 3Y

711.25%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-197,000
Depreciation and amortization	$1.6M
EBIT	$-216.3M
EBITDA	$-214.6M
EPS	$-2.18
FCF per share	$-1.98
Financing cash flow	$104.5M
Free cash flow	$-196.6M
Free cash flow minus SBC	$-227.8M
Gross profit	$68.2M
Income taxes	$-80,000
Investing cash flow	$48.5M
Net borrowing	$96.3M
Net cash flow	$-43.4M
Net income	$-215.4M
Operating cash flow minus SBC	$-227.6M
Operating income	$-216.3M
Revenue	$116.9M
Stock-based compensation	$31.2M

Metric

Value

Capital expenditures

$-197,000

Depreciation and amortization

$1.6M

EBIT

$-216.3M

EBITDA

$-214.6M

EPS

$-2.18

FCF per share

$-1.98

Financing cash flow

$104.5M

Free cash flow

$-196.6M

Free cash flow minus SBC

$-227.8M

Gross profit

$68.2M

Income taxes

$-80,000

Investing cash flow

$48.5M

Net borrowing

$96.3M

Net cash flow

$-43.4M

Net income

$-215.4M

Operating cash flow minus SBC

$-227.6M

Operating income

$-216.3M

Revenue

$116.9M

Stock-based compensation

$31.2M

Metric	Value
Altman Z-Score	-1.36
Book value per share	$0.13
Debt / equity	13.72
Interest coverage	-28.76
Long-term assets	$38M
Long-term liabilities	$176.1M
Net cash (debt)	$-27.8M
Net cash / market cap	-7.91%
Net debt / equity	2.22
Piotroski F-Score	1
Property, plant and equipment	$2.1M
Shareholders' equity	$12.5M
Tangible book value	$-1.4M
Tangible book value per share	$-0.01
Total assets	$249.5M
Total cash	$143.8M
Total debt	$171.6M
Total liabilities	$237M
WACC	7.99%

Metric

Value

Altman Z-Score

-1.36

Book value per share

$0.13

Debt / equity

13.72

Interest coverage

-28.76

Long-term assets

$38M

Long-term liabilities

$176.1M

Net cash (debt)

$-27.8M

Net cash / market cap

-7.91%

Net debt / equity

2.22

Piotroski F-Score

Property, plant and equipment

$2.1M

Shareholders' equity

$12.5M

Tangible book value

$-1.4M

Tangible book value per share

$-0.01

Total assets

$249.5M

Total cash

$143.8M

Total debt

$171.6M

Total liabilities

$237M

WACC

7.99%

Metric	Value
Asset turnover	0.42
Current assets	$211.5M
Current liabilities	$60.9M
Current ratio	3.48
Inventory turnover	4.77
Net working capital	$6.8M
Quick ratio	3.15
Working capital	$150.6M
Working capital turnover	0.61

Metric

Value

Asset turnover

0.42

Current assets

$211.5M

Current liabilities

$60.9M

Current ratio

3.48

Inventory turnover

4.77

Net working capital

$6.8M

Quick ratio

3.15

Working capital

$150.6M

Working capital turnover

0.61

Metric	Value
Buyback yield / dilution	-1.43%
Dividend yield	0%
Shareholder yield	-1.43%

Metric

Value

Buyback yield / dilution

-1.43%

Dividend yield

Shareholder yield

-1.43%

Metric	Value
150-day SMA	$6.82
1D price change	-2.28%
1M price change	-10.66%
1M total return	-10.66%
1W price change	-15.03%
1W total return	-15.03%
1Y price change	-61.87%
1Y return CAGR	-61.9%
1Y total return	-61.87%
20-day SMA	$4.13
200-day SMA	$7.47
3M price change	-36.72%
3M total return	-36.72%
3Y price change	5.04%
3Y return CAGR	1.65%
3Y total return	5.04%
50-day SMA	$4.67
50-day SMA vs 200-day SMA	50under200
52-week high	$13.15
52-week high date	2026-01-12
52-week low	$3.53
52-week low date	2026-10-28
6M price change	-54.15%
6M total return	-54.15%
All-time high	$18.90
All-time high date	2025-06-27
All-time low	$2.55
All-time low date	2023-09-20
Average true range (ATR)	$0.26
Average volume	1.6M
Beta (1Y)	2.87
Beta (2Y)	1.15
Beta (5Y)	1.08
Change from 52-week high	-72.28%
Change from 52-week low	3.4%
Change from all-time high	-80.71%
Change from all-time low	42.94%
Change from open	0.28%
Day's gap	-2.55%
Dollar volume	$8.1M
High price	$3.72
Low price	$3.53
Monthly RSI	36.3
Open price	$3.64
Position in 52-week range	60.53%
Premarket change	-0.27%
Premarket close	$3.73
Premarket price	$3.72
Previous close	$3.73
Price vs 150-day SMA	-46.52%
Price vs 20-day SMA	-11.66%
Price vs 200-day SMA	-51.22%
Price vs 50-day SMA	-21.95%
Relative volume	1.37
RSI	34.11
Sharpe ratio	-0.98
Sharpe ratio (3Y)	0.31
Sortino ratio	-1.28
Sortino ratio (3Y)	0.54
Volume	2.2M
Weekly RSI	29.97
YTD price change	-68.71%
YTD total return	-68.71%

Metric

Value

150-day SMA

$6.82

1D price change

-2.28%

1M price change

-10.66%

1M total return

-10.66%

1W price change

-15.03%

1W total return

-15.03%

1Y price change

-61.87%

1Y return CAGR

-61.9%

1Y total return

-61.87%

20-day SMA

$4.13

200-day SMA

$7.47

3M price change

-36.72%

3M total return

-36.72%

3Y price change

5.04%

3Y return CAGR

1.65%

3Y total return

5.04%

50-day SMA

$4.67

50-day SMA vs 200-day SMA

50under200

52-week high

$13.15

52-week high date

2026-01-12

52-week low

$3.53

52-week low date

2026-10-28

6M price change

-54.15%

6M total return

-54.15%

All-time high

$18.90

All-time high date

2025-06-27

All-time low

$2.55

All-time low date

2023-09-20

Average true range (ATR)

$0.26

Average volume

1.6M

Beta (1Y)

2.87

Beta (2Y)

1.15

Beta (5Y)

1.08

Change from 52-week high

-72.28%

Change from 52-week low

3.4%

Change from all-time high

-80.71%

Change from all-time low

42.94%

Change from open

0.28%

Day's gap

-2.55%

Dollar volume

$8.1M

High price

$3.72

Low price

$3.53

Monthly RSI

36.3

Open price

$3.64

Position in 52-week range

60.53%

Premarket change

-0.27%

Premarket close

$3.73

Premarket price

$3.72

Previous close

$3.73

Price vs 150-day SMA

-46.52%

Price vs 20-day SMA

-11.66%

Price vs 200-day SMA

-51.22%

Price vs 50-day SMA

-21.95%

Relative volume

1.37

RSI

34.11

Sharpe ratio

-0.98

Sharpe ratio (3Y)

0.31

Sortino ratio

-1.28

Sortino ratio (3Y)

0.54

Volume

2.2M

Weekly RSI

29.97

YTD price change

-68.71%

YTD total return

-68.71%

Metric	Value
Float	48M
Float percentage	48.3%
Shares change (QoQ)	0.02%
Shares change (YoY)	1.43%
Shares held by insiders	6.15%
Shares held by institutions	57.44%
Shares outstanding	99.4M
Short % of float	44.11%
Short % of shares	21.31%
Short ratio	14.7 days

Metric

Value

Float

48M

Float percentage

48.3%

Shares change (QoQ)

0.02%

Shares change (YoY)

1.43%

Shares held by insiders

6.15%

Shares held by institutions

57.44%

Shares outstanding

99.4M

Short % of float

44.11%

Short % of shares

21.31%

Short ratio

14.7 days

ARS Pharmaceuticals, Inc. (SPRY)

Price

Financial snapshot

Fair-value bridge

Latest news · SPRY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SPRY indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SPRY

Frequently asked questions